Solicitation for Nominations for Members of the U.S. Preventive Services Task Force (USPSTF), 379-380 [2023-28870]
Download as PDF
Federal Register / Vol. 89, No. 2 / Wednesday, January 3, 2024 / Notices
sales statistics, inventories, formulas,
patterns devices, manufacturing
processes, or customer names.
Josephine Liu,
Assistant General Counsel for Legal Counsel.
[FR Doc. 2023–28898 Filed 1–2–24; 8:45 am]
BILLING CODE 6750–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Solicitation for Nominations for
Members of the U.S. Preventive
Services Task Force (USPSTF)
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Solicits nominations for new
members of the USPSTF.
AGENCY:
The Agency for Healthcare
Research and Quality (AHRQ) invites
nominations of individuals qualified to
serve as members of the U.S. Preventive
Services Task Force (USPSTF).
DATES: Nominations must be received
electronically by March 15th of a given
year to be considered for appointment to
begin in January of the following year.
ADDRESSES: Submit your responses
electronically via: https://uspstfnomi
nations.ahrq.gov/register.
FOR FURTHER INFORMATION CONTACT:
Lydia Hill at (301) 427–1587.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Arrangement for Public Inspection
Nominations and applications are
kept on file at the Center for Evidence
and Practice Improvement, AHRQ, and
are available for review during business
hours. AHRQ does not reply to
individual nominations, but considers
all nominations in making
recommendation for appointment.
Information regarded as private and
personal, such as a nominee’s social
security number, home and email
addresses, home telephone and fax
numbers, or names of family members
will not be disclosed to the public in
accord with the Freedom of Information
Act. 5 U.S.C. 552(b)(6); 45 CFR 5.31(f).
ddrumheller on DSK120RN23PROD with NOTICES1
Nomination Submissions
Nominations must be submitted
electronically, and should include:
1. The applicant’s current curriculum
vitae and contact information, including
mailing address, and email address; and
2. A letter explaining how this
individual meets the qualification
requirements and how he or she would
contribute to the USPSTF. The letter
VerDate Sep<11>2014
18:32 Jan 02, 2024
Jkt 262001
should also attest to the nominee’s
willingness to serve as a member of the
USPSTF.
AHRQ will later ask people under
serious consideration for USPSTF
membership to provide detailed
information that will permit evaluation
of possible significant conflicts of
interest. Such information will concern
matters such as financial holdings,
consultancies, non-financial scientific
interests, and research grants or
contracts.
To obtain a diversity of perspectives,
AHRQ particularly encourages
nominations of women, members of
underrepresented populations, and
persons with disabilities. Interested
individuals can nominate themselves.
Organizations and individuals may
nominate one or more people qualified
for membership on the USPSTF at any
time. Individuals nominated prior to
March 15, 2023, who continue to have
interest in serving on the USPSTF
should be re-nominated.
Qualification Requirements
To qualify for the USPSTF and
support its mission, an applicant or
nominee should, at a minimum,
demonstrate knowledge, expertise, and
national leadership in the following
areas:
1. The critical evaluation of research
published in peer-reviewed literature
and in the methods of evidence review;
2. Clinical prevention, health
promotion and primary health care; and
3. Implementation of evidence-based
recommendations in clinical practice
including at the clinician-patient level,
practice level, and health-system level.
Additionally, the Task Force benefits
from members with expertise in the
following areas:
D Public Health
D Health Equity and The Reduction of
Health Disparities
D Application of Science to Health
Policy
D Decision modeling
D Dissemination and Implementation
D Behavioral Medicine/Clinical
Health Psychology
D Communication of Scientific
Findings to Multiple Audiences
Including Health Care Professionals,
Policy Makers, and the General Public.
Candidates with experience and skills
in any of these areas should highlight
them in their nomination materials.
Applicants must have no substantial
conflicts of interest, whether financial,
professional, or intellectual, that would
impair the scientific integrity of the
work of the USPSTF and must be
willing to complete regular conflict of
interest disclosures.
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
379
Applicants must have the ability to
work collaboratively with a team of
diverse professionals who support the
mission of the USPSTF. Applicants
must have adequate time to contribute
substantively to the work products of
the USPSTF.
Nominee Selection
Nominated individuals will be
selected for the USPSTF on the basis of
how well they meet the required
qualifications and the current expertise
needs of the USPSTF. It is anticipated
that new members will be invited to
serve on the USPSTF beginning in
January, 2025. All nominated
individuals will be considered;
however, strongest consideration will be
given to individuals with demonstrated
training and expertise in the areas of
Internal Medicine, Family Medicine,
and Obstetrics and Gynecology. AHRQ
will retain and may consider for future
vacancies nominations received this
year and not selected during this cycle.
Some USPSTF members without
primary health care clinical experience
may be selected based on their expertise
in methodological issues such as metaanalysis, analytic modeling, or clinical
epidemiology. For individuals with
clinical expertise in primary health care,
additional qualifications in
methodology would enhance their
candidacy.
Background
Under title IX of the Public Health
Service Act, AHRQ is charged with
enhancing the quality, appropriateness,
and effectiveness of health care services
and access to such services. 42 U.S.C.
299(b). AHRQ accomplishes these goals
through scientific research and
promotion of improvements in clinical
practice, including clinical prevention
of diseases and other health conditions.
See 42 U.S.C. 299(b).
The USPSTF, an independent body of
experts in prevention and evidencebased medicine, works to improve the
health of people nationwide by making
evidence-based recommendations about
the effectiveness of clinical preventive
services and health promotion. The
recommendations made by the USPSTF
address clinical preventive services for
adults and children, and include
screening tests, counseling services, and
preventive medications.
The USPSTF was first established in
1984 under the auspices of the U.S.
Public Health Service. AHRQ provides
ongoing scientific, administrative, and
dissemination support for the USPSTF’s
operation. See 42 U.S.C. 299b–4(a)(3).
Members are appointed by the Secretary
of the U.S. Department of Health and
E:\FR\FM\03JAN1.SGM
03JAN1
380
Federal Register / Vol. 89, No. 2 / Wednesday, January 3, 2024 / Notices
Human Services to serve four-year
terms. New members are selected each
year to replace those members who are
completing their appointments.
The USPSTF rigorously evaluates the
effectiveness of clinical preventive
services and formulating or updating
recommendations regarding the
appropriate provision of preventive
services. Current USPSTF
recommendations and associated
evidence reviews are available on the
internet (www.uspreventiveservices
taskforce.org).
USPSTF members meet three times a
year for two days in the Washington, DC
area or virtually if necessary. A
significant portion of the USPSTF’s
work occurs between meetings during
conference calls and via email
discussions. Member duties include
prioritizing topics, designing research
plans, reviewing and commenting on
systematic evidence reviews, discussing
evidence and making recommendations
on preventive services, reviewing
stakeholder comments, drafting final
recommendation documents, and
participating in workgroups on specific
topics and methods. Members can
expect to receive frequent emails, can
expect to participate in multiple
conference calls each month, and can
expect to have periodic interaction with
stakeholders. AHRQ estimates that
members devote approximately 250
hours a year outside of in-person
meetings to their USPSTF duties. The
members are all volunteers and do not
receive any compensation beyond
support for travel to attend the thrice
yearly meetings and trainings.
Dated: December 27, 2023.
Marquita Cullom,
Associate Director.
[FR Doc. 2023–28870 Filed 1–2–24; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2023–N–5653]
ddrumheller on DSK120RN23PROD with NOTICES1
Food and Drug Administration’s Draft
Report and Plan on Best Practices for
Guidance; Availability
AGENCY:
Food and Drug Administration,
HHS.
Notice of availability, request
for comments.
ACTION:
The Food and Drug
Administration (FDA or Agency) is
announcing the availability of a draft
document entitled ‘‘Food and Drug
SUMMARY:
VerDate Sep<11>2014
18:32 Jan 02, 2024
Jkt 262001
Administration’s Draft Report and Plan
on Best Practices for Guidance.’’ This
draft report responds to the
Consolidated Appropriations Act of
2023, which directs FDA to issue a
report identifying best practices for the
efficient prioritization, development,
issuance, and use of guidance
documents and a plan for
implementation of such best practices. It
also directs FDA to publish a draft
report and plan no later than 1 year after
enactment of the Consolidated
Appropriations Act and to consult with
stakeholders in developing the report
and implementation plan.
DATES: Submit either electronic or
written comments on the draft report
and plan by March 4, 2024.
ADDRESSES: You may submit comments
as follows:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
Instructions: All submissions received
must include the Docket No. FDA–
2023–N–5653 for ‘‘Draft Report and Plan
on Best Practices for Guidance.’’
Received comments will be placed in
the docket and, except for those
submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday, 240–402–7500.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://
www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852, 240–402–7500.
See the SUPPLEMENTARY INFORMATION
section for electronic access to the draft
report and plan.
FOR FURTHER INFORMATION CONTACT: Julie
Finegan, Office of Policy, Office of the
Commissioner, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 32, Rm. 4252, Silver Spring,
MD 20993–0002, 301–827–4830.
E:\FR\FM\03JAN1.SGM
03JAN1
Agencies
[Federal Register Volume 89, Number 2 (Wednesday, January 3, 2024)]
[Notices]
[Pages 379-380]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-28870]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Solicitation for Nominations for Members of the U.S. Preventive
Services Task Force (USPSTF)
AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.
ACTION: Solicits nominations for new members of the USPSTF.
-----------------------------------------------------------------------
SUMMARY: The Agency for Healthcare Research and Quality (AHRQ) invites
nominations of individuals qualified to serve as members of the U.S.
Preventive Services Task Force (USPSTF).
DATES: Nominations must be received electronically by March 15th of a
given year to be considered for appointment to begin in January of the
following year.
ADDRESSES: Submit your responses electronically via: https://uspstfnominations.ahrq.gov/register.
FOR FURTHER INFORMATION CONTACT: Lydia Hill at (301) 427-1587.
SUPPLEMENTARY INFORMATION:
Arrangement for Public Inspection
Nominations and applications are kept on file at the Center for
Evidence and Practice Improvement, AHRQ, and are available for review
during business hours. AHRQ does not reply to individual nominations,
but considers all nominations in making recommendation for appointment.
Information regarded as private and personal, such as a nominee's
social security number, home and email addresses, home telephone and
fax numbers, or names of family members will not be disclosed to the
public in accord with the Freedom of Information Act. 5 U.S.C.
552(b)(6); 45 CFR 5.31(f).
Nomination Submissions
Nominations must be submitted electronically, and should include:
1. The applicant's current curriculum vitae and contact
information, including mailing address, and email address; and
2. A letter explaining how this individual meets the qualification
requirements and how he or she would contribute to the USPSTF. The
letter should also attest to the nominee's willingness to serve as a
member of the USPSTF.
AHRQ will later ask people under serious consideration for USPSTF
membership to provide detailed information that will permit evaluation
of possible significant conflicts of interest. Such information will
concern matters such as financial holdings, consultancies, non-
financial scientific interests, and research grants or contracts.
To obtain a diversity of perspectives, AHRQ particularly encourages
nominations of women, members of underrepresented populations, and
persons with disabilities. Interested individuals can nominate
themselves. Organizations and individuals may nominate one or more
people qualified for membership on the USPSTF at any time. Individuals
nominated prior to March 15, 2023, who continue to have interest in
serving on the USPSTF should be re-nominated.
Qualification Requirements
To qualify for the USPSTF and support its mission, an applicant or
nominee should, at a minimum, demonstrate knowledge, expertise, and
national leadership in the following areas:
1. The critical evaluation of research published in peer-reviewed
literature and in the methods of evidence review;
2. Clinical prevention, health promotion and primary health care;
and
3. Implementation of evidence-based recommendations in clinical
practice including at the clinician-patient level, practice level, and
health-system level.
Additionally, the Task Force benefits from members with expertise
in the following areas:
[ssquf] Public Health
[ssquf] Health Equity and The Reduction of Health Disparities
[ssquf] Application of Science to Health Policy
[ssquf] Decision modeling
[ssquf] Dissemination and Implementation
[ssquf] Behavioral Medicine/Clinical Health Psychology
[ssquf] Communication of Scientific Findings to Multiple Audiences
Including Health Care Professionals, Policy Makers, and the General
Public.
Candidates with experience and skills in any of these areas should
highlight them in their nomination materials.
Applicants must have no substantial conflicts of interest, whether
financial, professional, or intellectual, that would impair the
scientific integrity of the work of the USPSTF and must be willing to
complete regular conflict of interest disclosures.
Applicants must have the ability to work collaboratively with a
team of diverse professionals who support the mission of the USPSTF.
Applicants must have adequate time to contribute substantively to the
work products of the USPSTF.
Nominee Selection
Nominated individuals will be selected for the USPSTF on the basis
of how well they meet the required qualifications and the current
expertise needs of the USPSTF. It is anticipated that new members will
be invited to serve on the USPSTF beginning in January, 2025. All
nominated individuals will be considered; however, strongest
consideration will be given to individuals with demonstrated training
and expertise in the areas of Internal Medicine, Family Medicine, and
Obstetrics and Gynecology. AHRQ will retain and may consider for future
vacancies nominations received this year and not selected during this
cycle.
Some USPSTF members without primary health care clinical experience
may be selected based on their expertise in methodological issues such
as meta-analysis, analytic modeling, or clinical epidemiology. For
individuals with clinical expertise in primary health care, additional
qualifications in methodology would enhance their candidacy.
Background
Under title IX of the Public Health Service Act, AHRQ is charged
with enhancing the quality, appropriateness, and effectiveness of
health care services and access to such services. 42 U.S.C. 299(b).
AHRQ accomplishes these goals through scientific research and promotion
of improvements in clinical practice, including clinical prevention of
diseases and other health conditions. See 42 U.S.C. 299(b).
The USPSTF, an independent body of experts in prevention and
evidence-based medicine, works to improve the health of people
nationwide by making evidence-based recommendations about the
effectiveness of clinical preventive services and health promotion. The
recommendations made by the USPSTF address clinical preventive services
for adults and children, and include screening tests, counseling
services, and preventive medications.
The USPSTF was first established in 1984 under the auspices of the
U.S. Public Health Service. AHRQ provides ongoing scientific,
administrative, and dissemination support for the USPSTF's operation.
See 42 U.S.C. 299b-4(a)(3). Members are appointed by the Secretary of
the U.S. Department of Health and
[[Page 380]]
Human Services to serve four-year terms. New members are selected each
year to replace those members who are completing their appointments.
The USPSTF rigorously evaluates the effectiveness of clinical
preventive services and formulating or updating recommendations
regarding the appropriate provision of preventive services. Current
USPSTF recommendations and associated evidence reviews are available on
the internet (www.uspreventiveservicestaskforce.org).
USPSTF members meet three times a year for two days in the
Washington, DC area or virtually if necessary. A significant portion of
the USPSTF's work occurs between meetings during conference calls and
via email discussions. Member duties include prioritizing topics,
designing research plans, reviewing and commenting on systematic
evidence reviews, discussing evidence and making recommendations on
preventive services, reviewing stakeholder comments, drafting final
recommendation documents, and participating in workgroups on specific
topics and methods. Members can expect to receive frequent emails, can
expect to participate in multiple conference calls each month, and can
expect to have periodic interaction with stakeholders. AHRQ estimates
that members devote approximately 250 hours a year outside of in-person
meetings to their USPSTF duties. The members are all volunteers and do
not receive any compensation beyond support for travel to attend the
thrice yearly meetings and trainings.
Dated: December 27, 2023.
Marquita Cullom,
Associate Director.
[FR Doc. 2023-28870 Filed 1-2-24; 8:45 am]
BILLING CODE 4160-90-P